NZOZ Centurm Medyczne SERAFIN-MED

At NZOZ Centurm Medyczne SERAFIN-MED in Żarów, the cardiovascular research portfolio focuses on major conditions such as atherosclerotic cardiovascular disease, atrial fibrillation, and multiple forms of heart failure. These trials are designed to test new treatments, reduce serious heart-related events, and improve long-term outcomes for people living with high-risk cardiac conditions.

• Evaluating therapies for elevated lipoprotein(a) and broader atherosclerotic cardiovascular disease
• Studying treatment options for atrial fibrillation with a focus on safety and bleeding risk
• Assessing new approaches for heart failure, including forms linked to obesity, inflammation, and reduced or preserved ejection fraction

These studies aim to improve prevention of cardiovascular complications, support better symptom control, and lower the risk of hospitalization and death.

The metabolic research at this site centers on obesity, overweight, hypertriglyceridemia, and severe hypertriglyceridemia. The trials are exploring new therapies that may help lower harmful blood fats, support weight-related health, and address metabolic problems that often overlap with cardiovascular disease.

• Testing treatments for obesity and overweight in people at elevated cardiovascular risk
• Evaluating therapies for hypertriglyceridemia and severe hypertriglyceridemia
• Exploring whether metabolic treatments can also improve kidney outcomes and reduce cardiovascular complications

Overall, this research aims to refine treatment strategies for patients whose metabolic disorders may contribute to broader heart and kidney health concerns.